Eckert & Ziegler: Merger with Belgian Eckert & Ziegler BEBIG SA Successfully Completed
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Merger Berlin, February 18, 2019. The merger between Eckert & Ziegler Strahlen- und Medizintechnik AG (EZAG) as absorbing company with the Belgian Eckert & Ziegler BEBIG SA (EZB) as absorbed company has become formally effective with today's entry into the commercial register of Berlin-Charlottenburg. As a result, trading in BEBIG shares listed on Euronext Brussels (ISIN BE0974300320) will cease on February 18, 2019. The objective of the merger is to streamline the corporate structure of the EZAG Group as well as the associated regulatory reporting. Dual stock exchange listings within the group mean higher administrative expenditures that are compensated by only minor economic benefits. Ending the stock exchange listing and the thus associated cost savings, reduces the annual expenditure of EZB significantly, including the statutory audit of the annual accounts. About Eckert & Ziegler. Contact:
18.02.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
Robert-Rössle-Str.10 | |
13125 Berlin | |
Germany | |
Phone: | 49 30 941084-138 |
Fax: | 49 30 941084-112 |
E-mail: | karolin.riehle@ezag.de |
Internet: | www.ezag.de |
ISIN: | DE0005659700 |
WKN: | 565970 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
End of News | DGAP News Service |